| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/06/1996 | CA2155451A1 Dna sequences encoding novel biosynthetic insulin precursors and process for preparation of insulin |
| 02/06/1996 | CA2056437C Production of virus and purification of viral envelope proteins for vaccine use |
| 02/06/1996 | CA1338032C Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/05/1996 | CA2155042A1 Process for the preparation of protein-rich product from brewer's spent grain |
| 02/01/1996 | WO1996002670A1 Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases |
| 02/01/1996 | WO1996002654A1 Toxoplasma gondii p30 protein expression cassette |
| 02/01/1996 | WO1996002649A1 Modified plant viruses as vectors of heterologous peptides |
| 02/01/1996 | WO1996002648A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 02/01/1996 | WO1996002647A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | WO1996002646A2 Growth control for cells encapsulated within bioartificial organs |
| 02/01/1996 | WO1996002645A2 Htk ligand |
| 02/01/1996 | WO1996002644A1 Mlk receptor tyrosine kinases |
| 02/01/1996 | WO1996002643A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 02/01/1996 | WO1996002642A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 02/01/1996 | WO1996002641A2 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
| 02/01/1996 | WO1996002640A1 Alpha-lactalbumin gene constructs |
| 02/01/1996 | WO1996002639A1 Constitutively activating adrenergic receptors |
| 02/01/1996 | WO1996002637A1 Method for extra-cellular expression of protein |
| 02/01/1996 | WO1996002575A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 02/01/1996 | WO1996002573A1 Separation of human serum albumin |
| 02/01/1996 | WO1996002572A2 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | WO1996002571A1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 02/01/1996 | WO1996002570A1 A method of converting a hydrophobic derivative of a polypeptide into the native form |
| 02/01/1996 | WO1996002569A1 Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 02/01/1996 | WO1996002568A1 Complexes for use in the diagnosis of vascular diseases |
| 02/01/1996 | WO1996002567A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | WO1996002566A1 Vitronectin binding protein |
| 02/01/1996 | WO1996002565A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | WO1996002563A1 Epstein-barr virus nuclear antigen 1 protein and its expression and recovery |
| 02/01/1996 | WO1996002562A1 Process for the purification of basic fibroblast growth factor |
| 02/01/1996 | WO1996002561A1 Interaction trap systems for detecting protein interactions |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002552A1 Lung cancer marker |
| 02/01/1996 | WO1996002286A1 Compositions and methods for a bioartificial extracellular matrix |
| 02/01/1996 | WO1996002269A1 Therapeutic method and compounds of use therein |
| 02/01/1996 | WO1996002143A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 02/01/1996 | WO1996002140A1 ISOLATED p27 PROTEIN AND METHODS FOR ITS PRODUCTION AND USE |
| 02/01/1996 | WO1995034668A3 The cytoplasmic inhibition of gene expression |
| 02/01/1996 | WO1995034655A3 Surface protein of staphylococcus aureus |
| 02/01/1996 | DE4439347A1 New rare earth or transition metal complexes contg. charged linker |
| 02/01/1996 | DE4439346A1 New rare earth or transition metal complexes contg. hydrophilic gps. |
| 02/01/1996 | DE4439345A1 New conjugates comprising oligomeric carrier and attached hapten(s) |
| 02/01/1996 | DE4430998A1 Metallchelat-markierte Peptide Metal chelate-labeled peptides |
| 02/01/1996 | DE4430973A1 Hapten-markierte Peptide Hapten-labeled peptides |
| 02/01/1996 | DE4430972A1 Bestimmung von spezifischem Immunglobulin unter Verwendung multipler Antigene Determination of specific immunoglobulin using multiple antigens |
| 02/01/1996 | DE4426429A1 Verfahren zum Einführen von DNA in höhere eukaryotische Zellen A method for introducing DNA into higher eukaryotic cells |
| 02/01/1996 | CA2694296A1 Growth control for cells encapsulated within bioartificial organs |
| 02/01/1996 | CA2195533A1 Interruption of binding of mdm2 and p53 protein and therapeutic application thereof |
| 02/01/1996 | CA2195531A1 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
| 02/01/1996 | CA2195474A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | CA2195403A1 Lung cancer marker |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195238A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | CA2195202A1 Separation of human serum albumin |
| 02/01/1996 | CA2195197A1 Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 02/01/1996 | CA2195126A1 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | CA2194955A1 Htk ligand |
| 02/01/1996 | CA2194873A1 Condii toxoplasma p30 expression cassette |
| 02/01/1996 | CA2194861A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | CA2194784A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 02/01/1996 | CA2194493A1 Compositions and methods for a bioartificial extracellular matrix |
| 02/01/1996 | CA2193513A1 Alpha-lactalbumin gene constructs |
| 01/31/1996 | EP0694562A1 Preparation of alpha-1-antichymotrypsin |
| 01/31/1996 | EP0694561A1 Calcitonin analogue and use thereof |
| 01/31/1996 | EP0694560A2 Production of antigens of Pasteurella |
| 01/31/1996 | EP0694080A1 Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome |
| 01/31/1996 | EP0694078A1 Method for screening for receptor agonists |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0694069A1 Variant insulin-like growth factor i receptor subunits and methods for use thereof |
| 01/31/1996 | EP0694067A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 01/31/1996 | EP0694066A1 Model for gonococcal infection |
| 01/31/1996 | EP0694062A1 New bacillus thuringiensis strains and their insecticidal proteins |
| 01/31/1996 | EP0694043A1 ANTIGENIC POLYPEPTIDES OF $i(T. OVIS) AND VACCINES CONTAINING SUCH POLYPEPTIDES |
| 01/31/1996 | EP0694042A1 Inhibitor of vascular endothelial cell growth factor |
| 01/31/1996 | EP0694041A1 A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING N-ALPHA-METHYLARGININE |
| 01/31/1996 | EP0693941A1 Radiolabeled compounds for thrombus imaging |
| 01/31/1996 | EP0693940A1 Hybrid genes for use in the production of t h?-independent cytotoxic t cells |
| 01/31/1996 | EP0693938A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 01/31/1996 | EP0693937A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
| 01/31/1996 | EP0693936A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 01/31/1996 | EP0693931A1 Immunogenic cancer proteins and peptides and method of use |
| 01/31/1996 | EP0693925A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
| 01/31/1996 | EP0693874A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 01/31/1996 | EP0673383A4 Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same. |
| 01/31/1996 | EP0634935A4 A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen. |
| 01/31/1996 | EP0538352B1 IMMUNOGENIC PEPTIDE SEQUENCE FROM $i(ECHINOCOCCUS GRANULOSUS), DNA SEQUENCE CODING FOR SAID PEPTIDE SEQUENCE, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 01/31/1996 | EP0502928B1 Methods of detecting bone resorption in vivo |
| 01/31/1996 | EP0491688B1 Methods for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography |
| 01/31/1996 | EP0455785B1 Leucocyte elastasis and cathepsin g-blocking peptide |
| 01/31/1996 | EP0423322B1 Grf analogs viia |
| 01/31/1996 | EP0305488B1 Mycobacterial recombinants and peptides |
| 01/31/1996 | CN1115990A Gene that identifies sterile plant cytoplasm and process for preparing hybrid plant by using the same |
| 01/30/1996 | US5488099 Multifunctional chimeric neurotrophic factors |
| 01/30/1996 | US5488035 Peptide with inhibitory activity towards plant pathogenic fungi |
| 01/30/1996 | US5488032 Method of using soluble human interleukin-1 receptors to suppress inflammation |
| 01/30/1996 | US5487992 Producing a transgenic mouse |
| 01/30/1996 | US5487991 Polypeptides and dna sequences for plants and proteins |
| 01/30/1996 | US5487990 Glucose-regulated promoter of yeast acetyl-CoA hydrolase |